Glaukos, D. Western partner for glaucoma therapies

Glaukos Corp. (NYSE:GKOS) partnered with D. Western Therapeutics Institute Inc. (Tokyo:4576) to explore combining compounds from D. Western's rho-associated coiled-coil containing protein kinase (ROCK) library with Glaukos' iDose drug delivery system to treat glaucoma. Glaukos is responsible for evaluation and development of the candidates...